High frequency of the IL-2 -330 T/HLA-DRB1*1501 haplotype in patients with multiple sclerosis

Clinical Immunology

Volumn 137, Issue 1, 2010, Pages 134-138

  Shahbazi, Majid ^a   Roshandel, Danial ^a   Ebadi, Hamid ^a   Fathi, Davood ^a   Zamani, Mahdi ^b   Boghaee, Mojdeh ^b   Mohammadhoseeeni, Mana ^a   Rshaidbaghan, Azam ^a   Bakhshandeh, Azam ^a   Shahbazi, Saleh ^a  

^a GOLESTAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Genetic susceptibility; HLA DRB1*1501; Interleukin 2; Multiple sclerosis; Polymorphism; Predisposing factor

Indexed keywords

HLA DR ANTIGEN; INTERLEUKIN 2;

ADULT; ALLELE; ANALYSIS; ARTICLE; CHILD; CONTROL GROUP; CONTROLLED STUDY; FEMALE; FISHER EXACT TEST; GENE INTERACTION; GENE LOCUS; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; POSITION; PRIORITY JOURNAL; PROMOTER REGION; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGE OF ONSET; FEMALE; GENE FREQUENCY; GENOTYPE; HAPLOTYPES; HLA-DR ANTIGENS; HUMANS; INTERLEUKIN-2; IRAN; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 77956612821     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2010.05.010     Document Type: Article

References (30)

1. Breij E.C., Brink B.P., Veerhuis R., van den Berg C., Vloet R., Yan R., Dijkstra C.D., van der Valk P., Bö L. Homogeneity of active demyelinating lesions in established multiple sclerosis. Ann. Neurol. 2008, 63:16-25.
2. Greer J.M., Csurhes P.A., Muller D.M., Pender M.P. Correlation of blood T cell and antibody reactivity to myelin proteins with HLA type and lesion localization in multiple sclerosis. J. Immunol. 2008, 180:6402-6410.
3. International Multiple Sclerosis Genetics Consortium, Hafler D.A., Compston A., Sawcer S., Lander E.S., Daly M.J., De Jager P.L., de Bakker P.I., Gabriel S.B., Mirel D.B., Ivinson A.J., et al. Risk alleles for multiple sclerosis identified by a genomewide study. N Engl J. Med. 2007, 357:851-862.
4. Wellcome Trust Case Control Consortium, Australo-Anglo-American Spondylitis Consortium (TASC), Burton P.R., Clayton D.G., Cardon L.R., Craddock N., Deloukas P., Duncanson A., Kwiatkowski D.P., McCarthy M.I., Ouwehand W.H., Samani N.J., et al. Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat. Genet. 2007, 39:1329-1337.
5. Shahbazi M., Ebadi H., Fathi D., Roshandel D., Mahamadhoseeni M., Rashidbaghan A., Mahammadi N., Mahammadi M.R., Zamani M. CCR5-Delta32 allele is associated with the risk of developing multiple sclerosis in the Iranian population. Cell. Mol. Neurobiol. 2009, 29:1205-1209.
6. Coraddu F., Reyes-Yanez M.P., Parra A., Gray J., Smith S.I., Taylor C.J., Compston D.A. HLA associations with multiple sclerosis in the Canary Islands. J. Neuroimmunol. 1998, 87:130-135.
7. Dyment D.A., Herrera B.M., Cader M.Z., Willer C.J., Lincoln M.R., Sadovnick A.D., Risch N., Ebers G.C. Complex interactions among MHC haplotypes in multiple sclerosis: susceptibility and resistance. Hum. Mol. Genet. 2005, 14:2019-2026.
8. Fernández O., R-Antigüedad A., Pinto-Medel M.J., Mendibe M.M., Acosta N., Oliver B., Guerrero M., Papais-Alvarenga M., Fernández-Sánchez V., Leyva L. HLA class II alleles in patients with multiple sclerosis in the Biscay province (Basque Country, Spain). J. Neurol. 2009 Jul 8, (Electronic publication ahead of print).
9. Australia and New Zealand Multiple Sclerosis Genetics Consortium (ANZgene), Bahlo M., Booth D.R., Broadley S.A., Brown M.A., Foote S.J., Griffiths L.R., Kilpatrick T.J., Lechner-Scott J., Moscato P., Perreau V.M., et al. Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20. Nat. Genet. 2009, 41:824-828.
10. Wandinger K.P., Stürzebecher C.S., Bielekova B., Detore G., Rosenwald A., Staudt L.M., McFarland H.F., Martin R. Complex immunomodulatory effects of interferon-beta in multiple sclerosis include the upregulation of T helper 1-associated marker genes. Ann. Neurol. 2001, 50:349-357.
11. Walker E., Leemhuis T., Roeder W. Murine B lymphoma cell lines release functionally active interleukin 2 after stimulation with Staphylococcus aureus. J. Immunol. 1988, 140:859-865.
12. Ho I.C., Kim J.I., Szabo S.J., Glimcher L.H. Tissue specific regulation of cytokine gene expression. Cold Spring Harb. Symp. Quant. Biol. 1999, 64:573-584.
13. Hoyer K.K., Dooms H., Barron L., Abbas A.K. Interleukin-2 in the development and control of inflammatory disease. Immunol. Rev. 2008, 226:19-28.
14. Sharief M.K., Thompson E.J. Correlation of interleukin-2 and soluble interleukin-2 receptor with clinical activity of multiple sclerosis. J. Neurol. Neurosurg. Psychiatry 1993, 56:169-174.
15. Kennedy M.K., Torrance D.S., Picha K.S., Mohler K.M. Analysis of cytokine mRNA expression in the central nervous system of mice with experimental autoimmune encephalomyelitis reveals that IL-10 mRNA expression correlates with recovery. J. Immunol. 1992, 149:2496-2505.
16. John S., Turner D., Donn R., Sinnott P., Worthington J., Ollier W.E.R., Hutchinson, Hajeer A.H. Two novel biallelic polymorphisms in the IL-2 gene. Eur. J. Immunogenet. 1998, 25:419-420.
17. Hoffmann S.C., Stanley E.M., Cox D.E., Craighead N., DiMercurio B.S., Koziol D.E., Harlan D.M., Kirk A.D., Blair P.J. Association of cytokine polymorphic inheritance and in vitro cytokine production in anti-CD3/CD28-stimulated peripheral blood lymphocytes. Transplantation 2001, 72:1444-1450.
18. Matesanz F., Fedetz M., Leyva L., Delgado C., Fernández O., Alcina A. Effects of the multiple sclerosis associated -330 promoter polymorphism in IL2 allelic expression. J. Neuroimmunol. 2004, 148:212-217.
19. Matesanz F., Fedetz M., Collado-Romero M., Fernández O., Guerrero M., Delgado C., Alcina A. Allelic expression and interleukin-2 polymorphisms in multiple sclerosis. J. Neuroimmunol. 2001, 119:101-105.
20. Ali Shokrgozar M., Sarial S., Amirzargar A., Shokri F., Rezaei N., Arjang Z., Radfar J., Yousefi-Behzadi M., Ali Sahraian M., Lotfi J. IL-2, IFN-gamma, and IL-12 gene polymorphisms and susceptibility to multiple sclerosis. J. Clin. Immunol. 2009, 29:747-751.
21. McDonald W.I., Compston A., Edan G., Goodkin D., Hartung H.P., Lublin F.D., McFarland H.F., Paty D.W., Polman C.H., Reingold S.C., Sandberg-Wollheim M., et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann. Neurol. 2001, 50:121-127.
22. Shahbazi M., Pravica V., Nasreen N., Fakhoury H., Fryer A.A., Strange R.C., Hutchinson P.E., Osborne J.E., Lear J.T., Smith A.G., et al. Association between functional polymorphism in EGF gene and malignant melanoma. Lancet 2002, 359:397-401.
23. Reynard M.P., Turner D., Navarrete C.V. Allele frequencies of polymorphisms of the tumour necrosis factor-alpha, interleukin-10, interferon-gamma and interleukin-2 genes in a North European Caucasoid group from the UK. Eur. J. Immunogenet. 2000, 27:241-249.
24. Ghabaee M., Bayati A., Amri Saroukolaei S., Sahraian M.A., Sanaati M.H., Karimi P., Houshmand M., Sadeghian H., Hashemi Chelavi L. Analysis of HLA DR2 and DQ6 (DRB1*1501, DQA1*0102, DQB1*0602) haplotypes in Iranian patients with multiple sclerosis. Cell. Mol. Neurobiol. 2009, 29:109-114.
25. Chao M.J., Barnardo M.C., Lincoln M.R., Ramagopalan S.V., Herrera B.M., Dyment D.A., Montpetit A., Sadovnick A.D., Knight J.C., Ebers G.C. HLA class I alleles tag HLA-DRB1*1501 haplotypes for differential risk in multiple sclerosis susceptibility. Proc. Natl Acad. Sci. USA 2008, 105:13069-13074.
26. Petitto J.M., Streit W.J., Huang Z., Butfiloski E., Schiffenbauer J. Interleukin-2 gene deletion produces a robust reduction in susceptibility to experimental autoimmune encephalomyelitis in C57BL/6 mice. Neurosci. Lett. 2000, 285:66-70.
27. Amirzargar A., Khosravi F., Dianat S., Hushmand F., Maryousef P., Foroushani A.R., Lotfi J., Nikbin B. Profile of cytokine gene polymorphisms in Iranian multiple sclerosis patients. Mult. Scler. 2007, 13:253-255.
28. Kikuchi S., Niino M., Fukazawa T., Yabe I., Tashiro K. An assessment of the association between IL-2 gene polymorphisms and Japanese patients with multiple sclerosis. J. Neurol. Sci. 2002, 205:47-50.
29. Marrosu M.G., Murru M.R., Costa G., Murru R., Muntoni F., Cucca F. DRB1-DQA1-DQB1 loci and multiple sclerosis predisposition in the Sardinian population. Hum. Mol. Genet. 1998, 7:1235-1237.
30. Duvefelt K., Anderson M., Fogdell-Hahn A., Hillert J. A NOTCH4 association with multiple sclerosis is secondary to HLA-DR*1501. Tissue Antigens 2004, 63:13-20.